Article
A novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell lines.
Leukemia
(2008)
Publication Date
October 1, 2008
DOI
10.1038/leu.2008.194
Citation Information
Z Diaz, K K Mann, S Marcoux, M Kourelis, et al.. "A novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell lines." Leukemia Vol. 22 Iss. 10 (2008) p. 1853 - 1863 Available at: http://works.bepress.com/zuanel-diaz/6/